インド - 英語 - Central Drugs Standard Control Organization

parenteral - glycine - sol3000 - 1.5g/100ml - 3000ml

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glycine - irrigation - 1.5% - irrigating solution for use in urological procedures and in cytoscopic examinations.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glycine - irrigation - 1.5%

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide - avocado plantation | banana plantation | barley | blackberry | boysenberry | cane berry fruit | canola | cereal grain | chickpea - amaranth or amaranthus | annual or wimmera ryegrass | apple-of-peru | argentine peppercress | awnless barnyard grass | barley grass | barnyard grass or water grass | bellvine | billygoat weed or blue top | bindweed | black bindweed | bladder ketmia | blady grass | bordered panic | brome grass | calopo | caltrop or yellow vine | cape tulip | capeweed | centro | clammy goosefoot | clover glycine | cobbler's pegs | common bittercress or flickweed | common fumitory | common storksbill | couch grass | cowpea | crowsfoot grass | deadnettle | dwarf amaranth or boggabri weed | fat hen | field bindweed | flaxleaf fleabane | foxtail millet | green crumbweed | greenleaf desmodium | indian hedge mustard | johnson grass | lesser canary grass | liverseed or urochloa grass | medic | mimosa invisa | mintweed | new zealand spinach | noogoora burr complex - suppression of | paddy melon | panic | paspalum spp. | paterson's curse | peach vine | perennial pigweed | pigweed spp. | pink shamrock | pinkburr | pinus spp. - regenerati

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

apotheca company - nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk), adenosine cyclic phosphate (unii: e0399ozs9n) (adenosine cyclic phosphate - unii:e0399ozs9n), calcium pantothenate (unii: 568et80c3d) (pantothenic acid - unii:19f5hk2737), choline hydroxide (unii: 7thj3eg9sy) (choline - unii:n91bdp6h0x), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), ubidecarenone (unii: ej27x76m46) (ubidecarenone - unii:ej27x76m46), glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - nadide 4 [hp_x] in 1 ml - indications:   for temporary relief of mental fatigue, for improving concentration, for improving energy, and for chronic fatigue. indications:   for temporary relief of mental fatigue, for improving concentration, for improving energy, and for chronic fatigue.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

nutrition diagnostics pty ltd - lysine hydrochloride, quantity: 133.68 mg/g (equivalent: lysine, qty 106.95 mg/g); citrus bioflavonoids extract, quantity: 53.475 mg/g; ascorbic acid, quantity: 427.8 mg/g; proline, quantity: 106.95 mg/g; glycine, quantity: 160.42 mg/g; camellia sinensis, quantity: 53.475 mg/g (equivalent: camellia sinensis, qty 1.604 g/g; equivalent: epigallocatechin-3-0-gallate, qty 21.39 mg/g; equivalent: caffeine, qty 535 microgram/g) - powder, oral - excipient ingredients: - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support energy levels ; helps convert (state food) into energy ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; aid/assist/helps connective tissue production/formation ; maintain/support bone health ; helps maintain/supports healthy joint cartilage growth/development/production ; helps maintain/support healthy cholesterol ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support blood capillary health ; aid/assist digestion/breakdown of dietary fat ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps reduce occurrence of common colds ; decrease/reduce/relieve common cold duration ; maintain/support skin health ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium citrate tetrahydrate, quantity: 770.14 mg (equivalent: calcium, qty 162.5 mg); salvia officinalis, quantity: 236.36 mg (equivalent: salvia officinalis, qty 1.3 g; equivalent: thujone, qty 3.55 mg); actaea racemosa, quantity: 4 mg (equivalent: actaea racemosa, qty 20 mg); glycine max, quantity: 86.25 mg (equivalent: glycine max, qty 13.8 g; equivalent: isoflavones calc daidzin/ein, genistin/ein, glycitin/ein (glycine max), qty 34.5 mg); colecalciferol, quantity: 0.0125 mg - tablet, film coated - excipient ingredients: povidone; macrogol 8000; crospovidone; croscarmellose sodium; microcrystalline cellulose; chlorophyllin-copper complex; magnesium stearate; maltodextrin; hypromellose; liquid glucose; titanium dioxide; colloidal anhydrous silica; carnauba wax; purified talc; polyvinyl alcohol; macrogol 3350; copper chlorophyllin; maize starch; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides - maintain/support healthy teeth ; maintain/support bone health ; help maintain/support bone mineralisation ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; decrease/reduce/relieve sleeplessness ; helps decrease/reduce/relieve night sweats associated with menopause ; decrease/reduce/relieve symptoms of menopause ; helps reduce occurrence of menopausal symptoms ; decrease/reduce/relieve hot flushes associated with menopause ; decrease/reduce/relieve aggression/irritability associated with menopause

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

nu skin enterprises australia inc - trifolium pratense, quantity: 80 mg (equivalent: trifolium pratense, qty 2 g); glycine max, quantity: 60 mg (equivalent: glycine max, qty 12 g; equivalent: isoflavone glycosides calc as genistin and daidzin (of glycine max), qty 21 mg); linum usitatissimum, quantity: 150 mg (equivalent: linum usitatissimum, qty 1.5 g; equivalent: lignans calc secoisolariciresinol diglucoside (linum usitatissimum seed), qty 30 mg); punica granatum, quantity: 40 mg (equivalent: punica granatum, qty 1.08 g); brassica oleracea var. botrytis, quantity: 150 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; stearic acid; gelatin; microcrystalline cellulose; purified water - maintain/support general health and wellbeing ; maintain/support female healthy hormonal balance ; maintain/support healthy female hormonal balance during menopause ; helps decrease/reduce/relieve night sweats associated with menopause ; decrease/reduce/relieve symptoms of menopause ; decrease/reduce/relieve hot flushes associated with menopause

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

cat media pty ltd - glycyrrhiza glabra, quantity: 62.5 mg (equivalent: glycyrrhiza glabra, qty 250 mg; equivalent: glycyrrhizinic acid, qty 12.5 mg); angelica polymorpha, quantity: 142.86 mg (equivalent: angelica polymorpha, qty 1 g); panax ginseng, quantity: 25 mg (equivalent: panax ginseng, qty 250 mg; equivalent: ginsenosides rg1- re- rf- rg2- rb1- rb2- rc- rd (of panax ginseng), qty 6.25 mg); actaea racemosa, quantity: 30 mg (equivalent: actaea racemosa, qty 300 mg; equivalent: triterpene glycosides calc 27-deoxyactein (of actaea racemosa), qty 1.5 mg); glycine max, quantity: 100 mg (equivalent: glycine max, qty 16 g; equivalent: isoflavones calc daidzin/ein, genistin/ein, glycitin/ein (glycine max), qty 40 mg); salvia officinalis, quantity: 90.91 mg (equivalent: salvia officinalis, qty 500 mg; equivalent: thujone, qty 1.36 mg); dioscorea villosa, quantity: 100 mg (equivalent: dioscorea villosa, qty 1 g); vitex agnus-castus, quantity: 40 mg (equivalent: vitex agnus-castus, qty 400 mg; equivalent: agnuside, qty 200 microgram; equivalent: aucubin (of vitex agnus-castus), qty 240 microgram); trifolium pratense, quantity: 250 mg (equivalent: trifolium pratense, qty 1 g; equivalent: isoflavones (of trifolium pratense), qty 6.25 mg) - tablet, film coated - excipient ingredients: maltodextrin; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; soy polysaccharide; sucrose; crospovidone; povidone; carnauba wax; macrogol 400; hypromellose; silicon dioxide; magnesium stearate; glucose monohydrate; colour - traditionally used in western herbal medicine to decrease/reduce/relieve mild rheumatic aches and pains ; traditionally used in western herbal medicine to decrease/reduce/relieve muscle pain/ache/soreness ; traditionally used in western herbal medicine to decrease/reduce/relieve nervous tension/unrest ; traditionally used in western herbal medicine to calmative/nervous system relaxant ; traditionally used in western herbal medicine to support healthy emotional/mood balance ; helps decrease/reduce/relieve night sweats associated with menopause ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of menopause ; decrease/reduce/relieve symptoms of menopause ; decrease/reduce/relieve hot flushes associated with menopause

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

baxter healthcare corporation - leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), tyrosine (unii: 42hk56048u) (tyrosine - unii:42hk56048u), arginine (unii: 94zla3w45f) (arginine - unii:94zla3w45f), proline (unii: 9dlq4ciu6v) (proline - unii:9dlq4ciu6v), alanine (unii: of5p57n2zx) (alanine - unii:of5p57n2zx), glutamic acid (unii: 3kx376gy7l) (glutamic acid - unii:3kx376gy7l), serine (unii: 452vly9402) (serine - unii:452vly9402), glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c), aspartic acid (unii: 30kyc7miai) (aspartic acid - unii:30kyc7miai), taurine (unii: 1eqv5mly3d) (taurine - unii:1eqv5mly3d), cysteine hydrochloride (unii: zt934n0x4w) (cysteine - unii:k848jz4886) - leucine 1.4 g in 100 ml - premasol 10% injection is indicated for the nutritional support of infants (including those of low birth weight) and young children requiring tpn via either central or peripheral infusion routes. parenteral nutrition with premasol 10% injection is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where: (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance (see dosage and administration). central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted infants, or those requiring long-term parenteral nutrition. for moderately catabolic or depleted patients in whom the central venous route is not indicated, diluted amino acid solutions mixed with 5-10% dextrose solutions may be infused by peripheral vein, supplemented, if desired, with fat emulsion. premasol 10% injection is contraindicated in patients with untreated anuria, hepatic coma, inborn errors of amino acid metabolism, including those involving branched chain amino acid metabolism such as maple syrup urine disease and isovaleric acidemia, or hypersensitivity to one or more amino acids present in the solution.